Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Nicholson

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
BMC Health Services Research|June 8, 2023
Exploring the psychological impact of contact tracing work on staff during the COVID-19 pandemicHugh Fulham-McQuillan, Róisín O'Donovan, Claire M Buckley, et al.
BMJ Open|January 8, 2025
Intestinal <i>M</i>icrobiota Transplant Prior to <i>A</i>llogeneic <i>S</i>tem Cell <i>T</i>ransplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trialBenjamin H Mullish, Andrew J Innes, Lauren A Roberts, et al.
Bone Marrow Transplantation|May 15, 2025
CAR-T cell manufacturing failures and out-of-specification products in the real-world setting: A survey from the EBMT cellular therapy and immunobiology working partyNina Worel, Jarl E Mooyaart, Jorinde D Hoogenboom, et al.
Bone Marrow Transplantation|January 4, 2026
Outcomes of patients with HTLV-1 adult T-cell leukemia/lymphoma (ATLL) after allogeneic SCT: results of the EBMT LWPPatricia López-Pereira, Ali Bazarbachi, Ambroise Marçais, et al.
Blood Cancer Journal|March 3, 2025
Risk factors for CAR T-cell manufacturing failure and patient outcomes in large B-cell lymphoma: a report from the UK National CAR T PanelVaishali Dulobdas, Amy A Kirkwood, Fabio Serpenti, et al.
Research Involvement and Engagement|August 9, 2020
Minding the gap: identifying values to enable public and patient involvement at the pre-commencement stage of research projectsÉidín Ní Shé, Jennifer Cassidy, Carmel Davies, et al.
Bone Marrow Transplantation|May 14, 2022
Comparison of fludarabine-melphalan and fludarabine-treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working PartyJesus Duque-Afonso, Jürgen Finke, Myriam Labopin, et al.
Bone Marrow Transplantation|August 27, 2024
Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMTUrban Novak, Jarl E Mooyaart, Michael Daskalakis, et al.
Leukemia Research|November 13, 2024
COVID-19 infection in adult and paediatric recipients of allogeneic stem cell transplantation: The UK experienceGiovanna Lucchini, Elena Cozma, Aimee Jackson, et al.
Hemasphere|February 26, 2026
Autologous stem cell transplantation in major T-cell lymphoma entities: An analysis by the EBMT Lymphoma Working PartyEvgenii Shumilov, Maud Ngoya, Philipp Berning, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
BMC Health Services Research|June 8, 2023
Exploring the psychological impact of contact tracing work on staff during the COVID-19 pandemicHugh Fulham-McQuillan, Róisín O'Donovan, Claire M Buckley, et al.
BMJ Open|January 8, 2025
Intestinal <i>M</i>icrobiota Transplant Prior to <i>A</i>llogeneic <i>S</i>tem Cell <i>T</i>ransplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trialBenjamin H Mullish, Andrew J Innes, Lauren A Roberts, et al.
Bone Marrow Transplantation|May 15, 2025
CAR-T cell manufacturing failures and out-of-specification products in the real-world setting: A survey from the EBMT cellular therapy and immunobiology working partyNina Worel, Jarl E Mooyaart, Jorinde D Hoogenboom, et al.
Bone Marrow Transplantation|January 4, 2026
Outcomes of patients with HTLV-1 adult T-cell leukemia/lymphoma (ATLL) after allogeneic SCT: results of the EBMT LWPPatricia López-Pereira, Ali Bazarbachi, Ambroise Marçais, et al.
Blood Cancer Journal|March 3, 2025
Risk factors for CAR T-cell manufacturing failure and patient outcomes in large B-cell lymphoma: a report from the UK National CAR T PanelVaishali Dulobdas, Amy A Kirkwood, Fabio Serpenti, et al.
Research Involvement and Engagement|August 9, 2020
Minding the gap: identifying values to enable public and patient involvement at the pre-commencement stage of research projectsÉidín Ní Shé, Jennifer Cassidy, Carmel Davies, et al.
Bone Marrow Transplantation|May 14, 2022
Comparison of fludarabine-melphalan and fludarabine-treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working PartyJesus Duque-Afonso, Jürgen Finke, Myriam Labopin, et al.
Bone Marrow Transplantation|August 27, 2024
Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMTUrban Novak, Jarl E Mooyaart, Michael Daskalakis, et al.
Leukemia Research|November 13, 2024
COVID-19 infection in adult and paediatric recipients of allogeneic stem cell transplantation: The UK experienceGiovanna Lucchini, Elena Cozma, Aimee Jackson, et al.
Hemasphere|February 26, 2026
Autologous stem cell transplantation in major T-cell lymphoma entities: An analysis by the EBMT Lymphoma Working PartyEvgenii Shumilov, Maud Ngoya, Philipp Berning, et al.
Pageof 12